NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
Mary Katherine Cheeley, Joseph J. Saseen, Anandita Agarwala, Sudha Ravilla, Nicole Ciffone, Terry A. Jacobson, Dave L. Dixon, Kevin C. Maki
Topics & Concepts
MedicineStatinAdverse effectDiscontinuationIntensive care medicineInternal medicinePhysical therapyLipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifeDiabetes, Cardiovascular Risks, and Lipoproteins